The Transfection Reagents And Equipment Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2024-2033).
Learn More On The Transfection Reagents And Equipment Market:
https://www.thebusinessresearchcompany.com/report/transfection-reagents-and-equipment-global-market-report
In accordance with The Business Research Company’s Global Market Report for Transfection Reagents And Equipment in 2024, the market has experienced substantial expansion in recent years, demonstrating a remarkable trajectory. Anticipated figures indicate a notable surge from $1.46 billion in 2024 to $1.62 billion in the same year, reflecting a compelling compound annual growth rate (CAGR) of 11.5%. This growth in the historical context finds its roots in burgeoning demands within biomedical research, pharmaceutical innovation, the proliferation of biotechnological applications, and the pivotal role of academic and research institutions, alongside significant advancements in genetic engineering.
Forecasts underscore a continued trajectory of rapid expansion within the transfection reagents and equipment market over the coming years, with an expected ascent to $2.43 billion by 2028, showcasing a robust CAGR of 10.6%. This upward trend can be attributed to the progressive evolution of gene therapy modalities, escalating demands for bioproduction capabilities, the emergence of cell-based therapies, extensive research and development endeavors in personalized medicine, and the fostering of global collaborative initiatives. Noteworthy trends in the forecast period encompass a pronounced emphasis on primary cell transfection methodologies, a discernible shift towards electroporation techniques, the seamless integration of nanotechnology into transfection processes, escalating demands for animal-free transfection reagents, and the increasing adoption of automation and high-throughput transfection systems.
The rising number of cancer patients worldwide is expected to propel the growth of the transfection reagents and equipment market going forward. Cancer is a group of diseases in which cells grow abnormally and uncontrollably. Transfection reagents are commonly used in cancer research to introduce foreign genetic material, such as plasmid DNA or RNA molecules, and allow researchers to investigate various aspects of cancer biology, such as gene expression studies, gene silencing, drug screening, and target validation. For instance, in 2021, according to the American Cancer Society, 1.8 million new cancer cases were diagnosed in 2020. Therefore, the rising number of cancer patients worldwide drives the growth of the transfection reagents and equipment market.
Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=10780&type=smp
The transfection reagents and equipment market covered in this report is segmented –
1) By Products: Instruments, Reagent And Kits
2) By Types Of Molecule: Plasmid DNA, DNA Oligonucleotides, Small Interfering RNA (SiRNA), Proteins, Ribonucleoprotein Complexes (RNPs), Other Molecules
3) By Organism: Bacteria, Mammalian Cells, Fungi, Plants, Virus
4) By End User: Biopharma, Contract Research Organizations (CROs), Contract Manufacturing Organizations (CMOs) And Contract Development And Manufacturing Organizations (CDMOs), Academia, Hospitals, Clinical Labs, Other End Users
Top 5 Major Players:
Moreover, a conspicuous trend gaining traction within the transfection reagents and equipment market is the primacy of product innovation. Leading enterprises within this domain are strategically prioritizing the development of groundbreaking solutions to fortify their market standing. A compelling illustration is evident in the initiatives of Polyplus-Transfection SA, a distinguished biotechnology firm headquartered in France. In September 2022, the company unveiled the in vivo-jetRNA+ transfection reagent, a pioneering solution for facilitating in vivo mRNA delivery utilizing a preformed liposome formulation. Distinguished by its exceptional efficacy and scalability, this innovative gene delivery system holds promise for diverse applications across various tissues and cell types. Notably, its safety profile and high tolerability render it a compelling option for advancing novel gene therapies. The ready-to-use structure obviates the need for formulation stages, while the stable liposome size enables a dynamic range of mRNA concentrations, spanning from low to high over time. Prominent applications encompass prophylactic vaccinations, mRNA-based treatments spanning cancer therapy, uncommon diseases, among others, as well as gene editing endeavors.
The transfection reagents and equipment market report table of contents includes:
1. Executive Summary
2. Transfection Reagents And Equipment Market Characteristics
3. Transfection Reagents And Equipment Market Trends And Strategies
4. Transfection Reagents And Equipment Market – Macro Economic Scenario
5. Global Transfection Reagents And Equipment Market Size and Growth
…..
31. Global Transfection Reagents And Equipment Market Competitive Benchmarking
32. Global Transfection Reagents And Equipment Market Competitive Dashboard
33. Key Mergers And Acquisitions In The Transfection Reagents And Equipment Market
34. Transfection Reagents And Equipment Market Future Outlook and Potential Analysis
35. Appendix
List Of Tables:
Table 1: Global Historic Market Growth, 2018-2023, $ Billion
Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
Table 3: Global Transfection Reagents And Equipment Market, Segmentation By Products, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 4: Global Transfection Reagents And Equipment Market, Segmentation By Types Of Molecule, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 5: Global Transfection Reagents And Equipment Market, Segmentation By Organism, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
…..
Table 75: Thermo Fisher Scientific Inc. Financial Performance
Table 76: Promega Corporation Financial Performance
Table 77: Qiagen N.V. Financial Performance
Table 78: Bio-Rad Laboratories Inc. Financial Performance
Table 79: Maxcyte Inc. Financial Performance
Related Reports:
https://topprnews.com/military-platform-electro-optics-market-report/
https://topprnews.com/military-power-solutions-market-report/
https://topprnews.com/military-sensors-market-size/
https://goodprnews.com/military-platform-electro-optics-market-report/
https://goodprnews.com/military-power-solutions-market-report/
https://goodprnews.com/military-sensors-market-size/
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
